Building Resilience: Overcoming Supply Chain Disruptions in Nutraceuticals
Supply chain volatility continues to challenge the nutraceutical industry. While disruptions are less severe than during the peak of the COVID-19 pandemic, issues such as port congestion and raw material shortages persist. For example, the U.S. Vitamin B9 (folic acid) market in Q2 2024 faced significant delays due to severe port congestion, threatening stockouts and lost market share for many brands.
Market Volatility and Economic Shifts
The first half of 2024 saw price volatility, especially in B-complex vitamins. Initially, prices surged due to high demand, only to drop later due to fluctuating consumer interest. This volatility is expected to continue, influenced by global economic conditions, including inflation and shifting demand patterns. Despite these challenges, the global nutraceutical market is projected to grow, with Asia-Pacific leading the way due to increased health awareness and disposable income.
Catalyst’s Approach to Navigating Supply Chain Volatility
Catalyst Nutraceuticals understands the need for agility and foresight in the face of supply chain disruptions. We work closely with our partners to develop tailored strategies to mitigate risks, such as adopting strategic supply chain agreements and creating demand planning strategies. By collaborating with us, you can lock in pricing for raw materials, implement blanket purchase orders, and reduce the risk of stockouts.
Collaborating for Success
Our open approach to collaboration ensures that brands can navigate the uncertainties of supply chain volatility effectively. At Catalyst, we are committed to transparency and working hand-in-hand with our partners to maintain product integrity and ensure reliable sourcing. Together, we can overcome market challenges and continue delivering high-quality products to consumers.